A Manifold prediction market indicates a 96.54% probability that Tesla will announce a formal partnership with Intel...
A Manifold prediction market indicates a 96.54% probability that Tesla will announce a formal partnership with Intel for an AI chip fabrication facility by June 30, 2026. This would mark a significant win for Intel's foundry business, potentially securing a major AI chip customer in Tesla. The partnership could signal a shift in the AI semiconductor landscape, challenging TSMC's dominance. However, the source is a single prediction market, and actual confirmation is pending. What the sources said: - Manifold market: 'Tesla announces formal Intel partnership for AI chip fab by June 30, 2026' has a YES consensus of 96.54%. Source
confidence score
Strong evidence: 1 independent source class support this read.
INTC is already up +152% over the recent 30-90 day window.
signal brief
A Manifold prediction market indicates a 96.54% probability that Tesla will announce a formal partnership with Intel for an AI chip fabrication facility by June 30, 2026. This would mark a significant win for Intel's foundry business, potentially securing a major AI chip customer in Tesla. The partnership could signal a shift in the AI semiconductor landscape, challenging TSMC's dominance. However, the source is a single prediction market, and actual confirmation is pending.
What the sources said:
- Manifold market: 'Tesla announces formal Intel partnership for AI chip fab by June 30, 2026' has a YES consensus of 96.54%. Source
source data used
“Manifold consensus on 'Will Intel manufacture NVIDIA chips by the end of 2026?': YES=27.00%”
“Manifold consensus on 'Tesla announces formal Intel partnership for AI chip fab by June 30, 2026': YES=96.54%”
“Manifold consensus on 'Will there be a joint venture chip foundry between TSMC and Intel? 🇺🇸🦾🤖💻': YES=48.73%”
“Manifold consensus on 'Will Intel's lithography catch up with TSMC by 2028?': YES=14.03%”
spillover entities
Decision support, not stock advice. This signal is research with cited evidence — not a recommendation to buy, sell, or hold any security.